References
- Wagstaff , A. J. , Cheer , S. M. , Matheson , A. J. , Ormrod , D. and Goa , K. L. 2002 . Paxoxetine: An update of its use in phychiatric disorders in adults . Drugs , 62 ( 4 ) : 655 – 703 .
- Gunasekara , N. S. , Noble , S. and Benfield , P. 1998 . Paxoxetine: An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders . Drugs , 55 ( 1 ) : 85 – 120 .
- Bloomer , J. C. , Woods , F. R. and Haddock , R. E. 1992 . The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes . Br. J. Clin. Pharmacol. , 33 ( 5 ) : 521 – 523 .
- Foglia , J. P. , Sorisio , D. , Kirshner , M. and Pollock , B. G. 1997 . Quantitative determination of paroxetine in plasma by high‐performance liquid chromatography and ultraviolet detection . J. Chromatogr. B , 693 ( 1 ) : 147 – 151 .
- Knoeller , J. , Vogt‐Schenkel , R. and Brett , M. A. 1995 . A simple and robust HPLC method for the determination of paroxetine in human plasma . J. Pharm. Biomed. Anal. , 13 ( 4–5 ) : 635 – 638 .
- Lopez‐Calcull , C. and Dominguez , N. 1999 . Determination of paroxetine in plasma by high‐performance liquid chromatography for bioequivalence studies . J. Chromatogr. B , 724 ( 2 ) : 393 – 398 .
- Shin , J. G. , Kim , K. A. , Yoon , Y. R. , Cha , I. J. , Kim , Y. H. and Shin , S. G. 1998 . Rapid simple high‐performance liquid chromatographic determination of paroxetine in human plasma . J. Chromatogr. B , 713 ( 2 ) : 452 – 456 .
- Brett , M. A. , Dierdorf , H. D. , Zussman , B. D. and Coates , P. E. 1987 . Determination of paroxetine in human plasma, using high‐performance liquid chromatography with fluorescence detection . J. Chromatogr. Biomed. Appl. , 63 : 438 – 444 .
- Lucca , A. , Gentilini , G. , Lopez–Silva , S. and Soldarini , A. 2000 . Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors by HPLC . Ther. Drug Monit. , 22 ( 3 ) : 271 – 276 .
- He , J. , Zhou , Z. L. and Li , H. D. 2005 . Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography‐electrospray ionization mass spectrometry (HPLC‐MS/ESI) . J. Chromatogr. B , 820 ( 1 ) : 33 – 39 .
- Naidong , W. and Eerkes , A. 2004 . Development and validation of a hydrophilic interaction liquid chromatography‐tandem mass spectrometric method for the analysis of paroxetine in human plasma . Biomed. Chromatogr. , 18 ( 1 ) : 28 – 36 .
- Zhu , Z. M. and Neirinck , L. 2002 . High‐performance liquid chromatography–mass spectrometry method for the determination of paroxetine in human plasma . J. Chromatogr. B , 780 ( 2 ) : 295 – 300 .
- Titier , K. , Castaing , N. , Scotto‐Gomez , E. , Pehourcq , F. , Moore , N. and Molimard , M. 2003 . High‐performance liquid chromatographic method with diode array detection for identification and quantification of the eight new antidepressants and five of their active metabolites in plasma after overdose . Ther. Drug Monit. , 25 ( 5 ) : 581 – 587 .
- Duverneuil , C. , de la Grandmaison , G. L. , de Mazancourt , P. and Alvarez , J. C. 2003 . A high‐performance liquid chromatography method with photodiode‐ array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs . Ther. Drug Monit. , 25 ( 5 ) : 565 – 573 .
- Leis , H. J. , Windischhofer , W. and Fauler , G. 2002 . Improved sample preparation for the quantitative analysis of paroxetine in human plasma by stable isotope dilution negative ion chemical ionization gas chromatography‐mass spectrometry . J. Chromatogr. B , 779 ( 2 ) : 353 – 357 .
- Leis , H. J. , Windischhofer , W. , Raspotnig , G. and Fauler , G. 2001 . Stable isotope dilution negative ion chemical ionization gas chromatography‐mass spectrometry for the quantitative analysis of paroxetine in human plasma . J. Mass Spectrom. , 36 ( 8 ) : 923 – 928 .
- Wille , S. M.R. , Maudens , K. E. , Van Peteghem , C. H. and Lambert , W. E.E. 2005 . Development of a solid phase extraction for 13 new generation antidepressants and their active metabolites for gas chromatographic‐mass spectrometric analysis . J. Chromatogr. A , 1098 ( 1–2 ) : 19 – 29 .
- Kristoffersen , L. , Bugge , A. , Lundanes , E. and Slordal , L. 1999 . Simultaneous determination of citalopram, fluoxetine, paroxetine and their active metabolites in plasma and whole blood by high‐performance liquid chromatography with ultraviolet and fluorescence detection . J. Chromatogr. B , 734 ( 2 ) : 229 – 246 .
- Molander , P. , Thomassen , A. , Kristoffersen , L. , Greibrokk , T. and Lundanes , E. 2001 . Simultaneous determination of citalopram, fluoxetine, paroxetine and their active metabolites in plasma by temperature‐programmed packed liquid chromatography with on‐column focusing of large injection volumes . J. Chromatogr. B , 766 ( 1 ) : 77 – 87 .
- Segura , M. , Ortuno , J. , Farre , M. , Pacifici , R. , Pichini , S. , Joglar , J. , Segura , J. and de‐la Torre , R. 2003 . Quantitative determination of paroxetine and its 4‐hydroxy‐3‐methoxy metabolite in plasma by high‐performance liquid chromatography/electrospray ion trap mass spectrometry: application to pharmacokinetic studies . Rapid Commun. Mass Spectrom. , 17 ( 13 ) : 1455 – 1461 .
- Moffat , A. C. , Osselton , M. D. and Widdop , B. 2004 . Clark's Analysis of Drugs and Poisons , 3rd Edn. Vol. 2 , London, Chicago : Pharmaceutical Press .
- Berridge , J. C. 1982 . Unattended optimization of reversed phase high performance liquid chromatographic separations using the modified Simplex algorithm . J. Chromatogr. , 244 : 1 – 14 .